Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes.
Respir Res
; 22(1): 62, 2021 Feb 19.
Article
in En
| MEDLINE
| ID: mdl-33608007
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quality of Life
/
Forced Expiratory Volume
/
Pulmonary Disease, Chronic Obstructive
/
Denervation
/
Lung
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Respir Res
Year:
2021
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido